OS Therapies Inc (OSTX)
↓ Download CSV| Metric (FY) | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating Income | -$28.71M | -$6.81M | -$4.34M | — |
| Net Income | -$28.75M | -$8.88M | -$7.79M | — |
| EPS (Diluted) | $-0.98 | $-1.28 | $-1.46 | — |
| Total Assets | $6.84M | $5.54M | $798.1K | — |
| Total Liabilities | $11.86M | $4.73M | $24.81M | — |
| Shareholders' Equity | -$6.10M | -$3.27M | -$24.02M | -$17.56M |
| Operating Cash Flow | -$14.24M | -$7.28M | -$3.01M | — |
| Capital Expenditures | $466.4K | — | — | — |
| Shares Outstanding | 37.11M | 20.87M | 5.34M | — |